The 5th Congress on Controversies in Leukemias (EUROLEUK 2024) is focused on basic science to clinical and therapeutic applications and perspectives.
The 5th Congress on Controversies in Leukemias (EUROLEUK 2024) covers topics such as:
- Leukemia stem cells (LSCs)
- Biology of ALL, AML, CML, CLL
- Allogeneic hematopoietic stem cell transplantation
- Routing diagnosis gene expression and mutational profiling
- Treatment of resistant/relapsed disease
- Front-line treatment of ALL, AML, CML, CLL
- Immunotherapy
- How novel agents are changing the treatment landscape of ALL, AML, CML and CLL
- Minimal residual disease
The 5th Congress on Controversies in Leukemias (EUROLEUK 2024) brings together:
- Biologists (BS)
- Senior or junior clinicians (MD, PhD, MD-PhD)
- R&D personnel
- Clinical residents in-training
- Pharmaceutical and industry professionals
The 5th Congress on Controversies in Leukemias (EUROLEUK 2024) might be held in Nov 2024.